Philips Sonicare FlexCare - Sonicare.com - Sonicare

More documents

Recommendations

Info

Table 2—Changes in GI scores after 2 and 4 weeks *Changes in GI scores from baseline at 2 and 4 weeks are statistically significant at P
Table 4—Change in number of bleeding sites after 2 and 4 weeks Parameter P value is from ANCOVA. SD = standard deviation; ANCOVA = analysis of covariance. N Baseline Sites 2 Weeks Change in sites 4 Weeks Change in sites FlexCare 87 44.72 ± 12.35 -24.07 ± 9.15 -31.59 ± 9.33 Oral-B P40 88 41.85 ± 11.91 -21.80 ± 7.57 -27.89 ± 9.06 P value .324 .029 tions at each visit and review of subject-reported adverse events demonstrated the safety of the tested products with respect to hard and soft tissues. Discussion The results from this 4-week clinical trial demonstrate a strong effect of the FlexCare on reducing plaque-induced gingival inflammation. This was reflected in a highly significant reduction of GI scores after 2 and 4 weeks of use. The positive outcome corroborates results obtained in similar studies conducted with other sonic toothbrushes. 16-18 It was further substantiated by significantly reduced PI scores and a drop in the number of bleeding sites by 70.6% over the 4-week period. Reductions in GI and PI scores were 28.4% and 43.9%, respectively, and associated score reductions between baseline and visit 3 were statistically significant. The results achieved with FlexCare clearly exceeded the efficacy thresholds of 15% for GI and statistical significance for PI established by the American Dental Association Acceptance Program 19 for power toothbrushes. This study also demonstrates that FlexCare offers statistically significantly greater plaque removal ability than a manual toothbrush. The observed treatment effect of 3.9% probably underestimated the true advantage that could be expected from using the FlexCare in a nontrial situation. For instance, all manual toothbrush users reported excellent compliance with instructions for brushing Figure 2—Number of gingival sites with GI score ≥2.0 at baseline (bleeding sites) by treatment group 45 40 FlexCare MTB 35 30 Number of bleeding sites 25 20 P = .324 P = .029 15 10 5 0 Baseline Week 2 Week 4 Weeks of product use P values were calculated from ANCOVA adjusted for baseline differences. GI = gingival index; MTB = manual toothbrush; ANCOVA = analysis of covariance. Vol. 28, No. 9 (Suppl 1) Compendium / September 2007 39
Page 1 and 2: An Ascend Media Publication Septemb
Page 3 and 4: Table of Contents 4 10 15 23 A New
Page 5 and 6: Figure 1—Cross-section of the new
Page 7 and 8: etains the optimized operating freq
Page 9 and 10: streams produced by the Sonicare Fl
Page 11 and 12: developed so that specific brush he
Page 13 and 14: Figure 2—Mean percentage biofilm
Page 15 and 16: Effect of the Sonicare FlexCare Pow
Page 17 and 18: Figure 2—Experimental system used
Page 19 and 20: Figure 4—Three-dimensional view o
Page 21 and 22: 4 x 10 -5 Mass transfer 3 x 10 -5 c
Page 23 and 24: A Randomized, Crossover Study to Co
Page 25 and 26: Table 1—Sample demographics (N =
Page 27 and 28: Figure 3—Estimated treatment effe
Page 29 and 30: A Randomized, Single-use Study to C
Page 31 and 32: Table 1—Summary of subject charac
Page 33 and 34: Figure 3—Estimated treatment effe
Page 35 and 36: A Randomized, Parallel-design Study
Page 37: hygiene measures were allowed durin
Page 41 and 42: Affairs. Acceptance Program Guideli
Page 43 and 44: Figure 1—Dentin samples embedded
Page 45 and 46: Gloss (GU) 120 100 80 60 40 20 0 So
Page 47 and 48: Table 2—Gloss measurements (GU) a
Page 49 and 50: Table 3—Wear of dentin samples af

Philips Sonicare FlexCare - Sonicare.com - Sonicare

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?